dalteparin has been researched along with glucuronic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, LG; Camara, RB; Cordeiro, SL; Costa, LS; Costa, MS; Dantas-Santos, N; Fidelis, GP; Nobre, LT; Rocha, HA | 1 |
| Bagre, AP; Jain, K; Jain, NK | 1 |
| Alekseeva, A; Cassinelli, G; Casu, B; Guerrini, M; Naggi, A; Torri, G | 1 |
| Alekseeva, A; Bisio, A; Gardini, C; Guerrini, M; Mazzini, G; Naggi, A | 1 |
4 other study(ies) available for dalteparin and glucuronic acid
| Article | Year |
|---|---|
Heterofucans from the brown seaweed Canistrocarpus cervicornis with anticoagulant and antioxidant activities.
Topics: Anticoagulants; Antioxidants; Drug Discovery; Enoxaparin; Free Radical Scavengers; Fucose; Galactose; Glucuronic Acid; Heparin, Low-Molecular-Weight; Humans; Iron Chelating Agents; Oceans and Seas; Partial Thromboplastin Time; Phaeophyceae; Polysaccharides; Seaweed; Sulfates | 2011 |
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anticoagulants; Biological Availability; Chitosan; Drug Carriers; Enoxaparin; Glucuronic Acid; Hexuronic Acids; Intestinal Mucosa; Nanoparticles; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2013 |
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Topics: Borohydrides; Chromatography, Reverse-Phase; Dalteparin; Enoxaparin; Glucuronic Acid; Heparin Lyase; Heparin, Low-Molecular-Weight; Hydrolysis; Iduronic Acid; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Periodic Acid; Tinzaparin | 2014 |
Saturated tetrasaccharide profile of enoxaparin. An additional piece to the heparin biosynthesis puzzle.
Topics: Chromatography, High Pressure Liquid; Enoxaparin; Fibrinolytic Agents; Glucosamine; Glucuronic Acid; Heparin; Heparin Lyase; Humans; Iduronic Acid; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oligosaccharides | 2021 |